pipette
ESEspañol

Prime editing of human hematopoietic stem cells for correction of GATA2 deficiency

Jonas Holst Wolff, Thomas Wisbech Skov, Sofie Rahbek Dorset, Janni Sjelborg, Sujan Ravendran, Anne Louise Revenfeld, Didde Haslund, Anaïs Marie Julie Møller, Mette Holm, Martin Kristian Thomsen, Trine Hyrup Mogensen, Bjarne Kuno Møller, Rasmus Otkjær Bak, Jacob Fog Bentzon

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Here, we report the development of an efficient gene editing therapy for GATA2 deficiency using prime editing with a favorable safety profile in terms of off-target effects and genotoxicity.

Appeared: Friday, October 2. Science Translational Medicine. Peer-reviewed journal.

DOI: 10.1126/scitranslmed.aec7031